Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -79.13%. However, over the past six months, we’ve seen a stronger performance of -32.91%. The price of PTPI fallen by 9.00% over the last 30 days. And in the last five days, it has fallen by -41.16%.
In terms of market performance, Petros Pharmaceuticals Inc had a fairly uneven. The highest value for the stock in the past year was $2.27 on 02/14/24, and the lowest value was recorded at $0.22 on 11/15/24.
52-week price history of PTPI Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Petros Pharmaceuticals Inc’s current trading price is -87.31% away from its 52-week high, while its distance from the 52-week low is 30.48%. The stock’s price range during this period has varied between$0.22 and $2.27. The Petros Pharmaceuticals Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.23 million for the day, a figure considerably lower than their average daily volume of 1.55 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Petros Pharmaceuticals Inc (PTPI) has experienced a quarterly decline of -11.17% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.95M and boasts a workforce of 21 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.3337, with a change in price of -0.1069. Similarly, Petros Pharmaceuticals Inc recorded 1,030,908 in trading volume during the last 100 days, posting a change of -27.06%.
PTPI’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for PTPI stands at 2.32. Similarly, the long-term debt-to-equity ratio is also 1.58.
PTPI Stock Stochastic Average
Petros Pharmaceuticals Inc’s raw stochastic average for the past 50 days is presently 18.45%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 11.35%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 11.63% and 16.74%, respectively.
